Objective

• Facilitate the development of advanced medical products at a global standard through lifecycle support.
• Provide strategic decision-making support at each phase of development to accelerate the path to commercialization.

Key Features

• Implement an integrated development support program that connects foundational technology infrastructure with regulatory consulting from the strategy formulation phase through to commercialization.
• Deliver regulatory insights for biopharmaceuticals and advanced medical devices.

Eligibility

• Biopharmaceuticals (antibody drugs, protein drugs, biosimilars, etc.)
• Advanced biopharmaceuticals (cell therapies, gene therapies, integrated medical products, etc.)
• Medical devices (high-risk human implantable medical devices, optical integrated medical devices, in vitro diagnostic devices, etc.)